Michael B. Fowler, MB, FRCP
Academic Appointments
- Professor - Med Center Line, Medicine - Cardiovascular Medicine
Key Documents
Contact Information
-
Clinical Offices
Cardiovascular Medicine Clinic 300 Pasteur Dr MC 5319 A260 Stanford, CA 94305 Tel Work (650) 723-6459 Fax (650) 498-7452
- Academic Offices
Personal Information Email Tel (650) 723-7846Alternate Contact Edralin Laus Administrative Assistant Email Tel Work (650) 723-7846Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cardiology (Heart)
- Cardiovascular Medicine
- Heart and Lung Transplantation
- Heart Failure
- Cardiomyopathy
Administrative Appointments
- Medical Director, CardiomyopathyCenter, Stanford University Medical Center (2001 - present)
- Director, Heart Failure Program, Stanford University Medical Center (2001 - present)
- Professor of Medicine, CardiovascularMedicine, Stanford University Medical Center (1999 - present)
- Assoc. Prof. of Medicine, CardiovascularMedicine, Stanford University Medical Center (1993 - 1999)
- Co-Director, Heart Failure Clinic, Stanford University Medical Center (1991 - 2001)
- Assistant Professor of Medicine, CardiovascularMedicine, Stanford University Medical Center (1986 - 1993)
Professional Education
| Residency: | Brighton and Sussex Medical School, England (1979) |
| Fellowship: | Brighton and Sussex Medical School, England (1979) |
| Fellowship: | Stanford University School of Medicine CA (1984) |
| Medical Education: | Charing Cross Hospital Medical School, U.K. (1975) |
| Residency: | Kent & Canterbury Hospital, England (1977) |
| Internship: | New Charing Hosp - London (1976) |
Scientific Focus
Current Research Interests
Adrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.
Publications
- Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy. J Card Fail. 2012; (10): 804-9
- Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented? Heart Fail Clin. 2011; (3): 333-44
- Dyssynchrony Assessment with Tissue Doppler Imaging and Regional Volumetric Analysis by 3D Echocardiography Do Not Predict Long-Term Response to Cardiac Resynchronization Therapy. Cardiol Res Pract. 2010: 568918
- Measurement precision in the optimization of cardiac resynchronization therapy. Circ Heart Fail. 2010; (3): 395-404
- Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy. Echocardiography. 2009; (7): 759-65
- Hypertension, heart failure, and beta-adrenergic blocking drugs. J Am Coll Cardiol. 2008; (13): 1073-5
Help